Evidence map›Paper›PMID 35551276›Full record

ArticlePloS one2022

Artificial neural network in the discrimination of lung cancer based on infrared spectroscopy.

Eiron John Lugtu, Denise Bernadette Ramos, Alliah Jen Agpalza, Erika Antoinette Cabral, Rian Paolo Carandang, Jennica Elia Dee, Angelica Martinez, Julius Eleazar Jose, Abegail Santillan, Ruth Bangaoil and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Eiron John LugtuDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.ORCID 0000-0002-6534-7211
Denise Bernadette RamosDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.ORCID 0000-0001-9396-2708
Alliah Jen AgpalzaDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.ORCID 0000-0002-2027-8785
Erika Antoinette CabralDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.ORCID 0000-0003-4291-8277
Rian Paolo CarandangDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.
Jennica Elia DeeDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.
Angelica MartinezDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.
Julius Eleazar JoseDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.
Abegail SantillanResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.
Ruth BangaoilResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.
Pia Marie AlbanoResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.ORCID 0000-0002-5024-8819
Rock Christian TomasDepartment of Electrical Engineering, University of the Philippines Los Baños, Laguna, Philippines.
University of Santo Tomas · PHUniversity of Santo Tomas Hospital · PHUniversity of the Philippines Los Baños · PH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the increasing prevalence of lung cancer worldwide, an auxiliary diagnostic method is needed alongside the microscopic examination of biopsy samples, which is dependent on the skills and experience of pathologists. Thus, this study aimed to advance lung cancer diagnosis by developing five (5) artificial neural network (NN) models that can discriminate malignant from benign samples based on infrared spectral data of lung tumors (n = 122; 56 malignant, 66 benign). NNs were benchmarked with classical machine learning (CML) models. Stratified 10-fold cross-validation was performed to evaluate the NN models, and the performance metrics-area under the curve (AUC), accuracy (ACC) positive predictive value (PPV), negative predictive value (NPV), specificity rate (SR), and recall rate (RR)-were averaged for comparison. All NNs were able to outperform the CML models, however, support vector machine is relatively comparable to NNs. Among the NNs, CNN performed best with an AUC of 92.28% ± 7.36%, ACC of 98.45% ± 1.72%, PPV of 96.62% ± 2.30%, NPV of 90.50% ± 11.92%, SR of 96.01% ± 3.09%, and RR of 89.21% ± 12.93%. In conclusion, NNs can be potentially used as a computational tool in lung cancer diagnosis based on infrared spectroscopy of lung tissues.

Indexed as

Brain NeoplasmsLung NeoplasmsArea Under CurveHumansMachine LearningNeural Networks, ComputerSpectrophotometry, Infrared

Identifiers

PMID35551276
PMCPMC9098097
OpenAlexW4280581276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.